Quantifying CDK inhibitor selectivity in live cells
Cyclin-dependent kinase (CDK) inhibitors are widely used both in the clinic and for basic research aimed at dissecting the specific cellular functions of specific CDKs. Here, the authors report the development of a panel of fluorescent reporter probes and provide a comprehensive profile of the inhib...
Enregistré dans:
Auteurs principaux: | Carrow I. Wells, James D. Vasta, Cesear R. Corona, Jennifer Wilkinson, Chad A. Zimprich, Morgan R. Ingold, Julie E. Pickett, David H. Drewry, Kathryn M. Pugh, Marie K. Schwinn, Byounghoon (Brian) Hwang, Hicham Zegzouti, Kilian V. M. Huber, Mei Cong, Poncho L. Meisenheimer, Timothy M. Willson, Matthew B. Robers |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5ab2cf72cb7f4b5ea0a65e02f4e02daf |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
PKIS deep dive yields a chemical starting point for dark kinases and a cell active BRSK2 inhibitor
par: Tigist Y. Tamir, et autres
Publié: (2020) -
Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2
par: Lindsey R. Pack, et autres
Publié: (2021) -
Three decades of Cdk5
par: Ping-Chieh Pao, et autres
Publié: (2021) -
CDK1 phosphorylates WRN at collapsed replication forks
par: Valentina Palermo, et autres
Publié: (2016) -
The Role of CDK4 in the Pathogenesis of Pancreatic Cancer
par: Emily Jiggens, et autres
Publié: (2021)